DIALA Trademark

Trademark Overview

On Tuesday, December 1, 2020, a trademark application was filed for DIALA with the United States Patent and Trademark Office. The USPTO has given the DIALA trademark a serial number of 90351179. The federal status of this trademark filing is REGISTERED as of Tuesday, July 26, 2022. This trademark is owned by D&D Biopharmaceuticals Inc.. The DIALA trademark is filed in the Pharmaceutical Products category with the following description:

A system for eye dilation comprised of ophthalmic solutions
diala

General Information

Serial Number90351179
Word MarkDIALA
Filing DateTuesday, December 1, 2020
Status700 - REGISTERED
Status DateTuesday, July 26, 2022
Registration Number6800054
Registration DateTuesday, July 26, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements

Goods and ServicesA system for eye dilation comprised of ophthalmic solutions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 5, 2021
Primary Code005
First Use Anywhere DateWednesday, March 3, 2021
First Use In Commerce DateWednesday, March 3, 2021

Trademark Owner History

Party NameD&D Biopharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSterling, VA 20164
Party NameD&D Biopharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVienna, VA 22182
Party NameD&D Biopharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVienna, VA 22182

Trademark Events

Event DateEvent Description
Wednesday, November 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 26, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 26, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 4, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, October 9, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Friday, October 8, 2021USE AMENDMENT ACCEPTED
Saturday, September 4, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, September 4, 2021FINAL REFUSAL E-MAILED
Saturday, September 4, 2021FINAL REFUSAL WRITTEN
Tuesday, August 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 7, 2021NON-FINAL ACTION E-MAILED
Friday, May 7, 2021NON-FINAL ACTION WRITTEN
Friday, April 30, 2021ASSIGNED TO EXAMINER
Friday, March 5, 2021AMENDMENT TO USE PROCESSING COMPLETE
Friday, March 5, 2021USE AMENDMENT FILED
Thursday, March 4, 2021TEAS AMENDMENT OF USE RECEIVED
Friday, February 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 4, 2020NEW APPLICATION ENTERED

Related Keywords

diala solutions ophthalmic comprised dilation system